Teva ready to divest operations to win regulatory nod for Mylan buy

April 22, 2015 1:48 PM

48 0

April 22 (Reuters) - Teva Pharmaceutical Industries Ltd said on Wednesday it could "promptly" divest some operations if necessary to obtain regulatory clearance for its proposed takeover of smaller rival Mylan NV.

Teva unveiled an unsolicited $40 billion bid on Tuesday for Mylan in an attempt to ease pressure for new revenue sources.

Also read: Chip Maker Qualcomm Buying NXP Semiconductors in $38.1B Deal

Read more

To category page